Genome sequencing is becoming more affordable than ever before – several companies in the industry say the $1,000 personal genome is just around the corner. But, even if you can afford it, is mapping your genes worth it if you don’t have a specific medical condition to consider?
Despite the whole “knowledge is power” argument – it could help with early diagnosis and prevention or lead a doctor to better treatment options for an existing condition – sequencing skeptics raise valid concerns and questions when it comes to gene sequencing for healthy people. How precise is it? How well will consumers be able to interpret the results? Will it just lead to needless hand-wringing about conditions that people won’t be able to do to much to address or that won’t surface until much later in life?
To read the full, original article click on this link: As genome sequencing becomes more affordable should you do it? — Tech News and Analysis
